Auwaerter on Infectious Diseases

Paul G. Auwaerter, MD, Clinical Director, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD
Paul G. Auwaerter, MD, MBA, has disclosed no relevant financial relationships. Dr. Auwaerter is a paid consultant to Medscape, and his participation and contributions do not constitute endorsement by The Johns Hopkins University, Hospital, or Health System.

Late Summer Fevers: History Is Paramount Dr Paul Auwaerter runs through his list of the most likely suspects when encountering a seasonal fever in the absence of pathognomonic features.
Medscape Infectious Diseases, August 14, 2023
New and Emerging Options for Treating Recurrent C difficile Paul G. Auwaerter, MD, discusses treatment options for recurrent C difficile, including new FDA-approved fecal microbiota products.
Medscape Infectious Diseases, July 28, 2023
From ECCMID: New Anti-Viral and Bacterial Drugs of Interest Infectious disease expert Dr Paul Auwaerter discusses news from ECCMID, including data on invasive group A streptococcus infections, and the new drugs ensitrelvir, gepotidacin, and sulbactam-durlobactam.
Medscape Infectious Diseases, June 05, 2023
COVID-19 Rebound: Is Treatment Worth It? Infectious disease expert Dr Paul Auwaerter reviews what is currently known about COVID-19 rebound in both treated and untreated patients, and explains why he thinks treatment can still be helpful.
Medscape Infectious Diseases, May 26, 2023
Hit Pandemic Show Is Fantastical but Not Baseless As a culture, we don't seem to be tiring of outbreak fiction, but a new series has something new to add to the genre, according to infectious disease expert Dr Paul Auwaerter.
Medscape Infectious Diseases, February 07, 2023
Measles in the United States: Should We Worry? Paul G. Auwaerter, MD, discusses measles, vaccination, and herd immunity.
Medscape Infectious Diseases, February 06, 2023
IDWeek 2022 IDWeek 2022: COVID News for Clinical Practice or FDA Consideration Paul Auwaerter, MD, discusses results from abstracts presented at IDWeek 2022 related to COVID-19 that may be interesting for clinical practice or may appear in front of the FDA soon.
Medscape Infectious Diseases, November 09, 2022
Should I Be Immunized, and When? A COVID-19 Booster Update Paul Auwaerter, MD, provides an update on COVID-19 boosters.
Medscape Infectious Diseases, September 14, 2022
Monkeypox and HIV: Same but Different? The first months of the global monkeypox outbreak are reminiscent of the early HIV days.
Medscape Infectious Diseases, August 09, 2022
COVID-19: Updates and Predictions for the Bivalent Booster Is it better to get the current booster now or to wait until the fall for boosters that cover the BA.4 and BA.5 variants?
Medscape Infectious Diseases, July 27, 2022
Monkeypox Outbreak: Monitoring, Diagnosis, and Treatment Dr Paul Auwaerter discusses the current monkeypox outbreak and highlights information related to diagnosis and treatment.
Medscape Infectious Diseases, June 08, 2022
Paxlovid Rebound: What Is Happening? Dr Paul Auwaerter discusses Paxlovid rebound and the use of investigational drugs.
Medscape Infectious Diseases, May 13, 2022
A Surprising Cause of Abdominal Pain and Other GI Symptoms Dr Paul Auwaerter discusses two patients with surprising causes of gastrointestinal symptoms.
Medscape Infectious Diseases, April 14, 2022
Is the Epstein-Barr Virus Associated With COVID-19? Dr Paul Auwaerter discusses recent studies investigating the potential association of the Epstein-Barr virus with COVID-19.
Medscape Infectious Diseases, March 17, 2022
Treatment Considerations for Pregnant Women With COVID-19 Dr Paul Auwaerter discusses the available treatments for COVID-19 in the context of recent data, focusing on safety for pregnant women.
Medscape Infectious Diseases, October 07, 2021
A Quick Tour of the New Lyme Disease Guideline Dr Paul Auwaerter highlights the major changes in this guideline, which was a collaboration of the IDSA, AAN, and ACR.
Medscape Infectious Diseases, June 14, 2021
COVID-19: Updated Mask Guidance From the CDC Dr Paul Auwaerter discusses the recent updated mask guidance from the CDC, noting that some consideration should be taken based on community rates in different areas.
Medscape Infectious Diseases, May 24, 2021
Monoclonals for COVID-19 a 'Minor Contribution' Using monoclonal antibodies may not be the easiest path to helping your outpatients with COVID-19, says Dr Paul Auwaerter.
Medscape Infectious Diseases, December 07, 2020
SARS-CoV-2 Diagnostics, From Serology to Spit Dr Paul Auwaerter gives an overview of the session on SARS-CoV-2 diagnostics from the Chasing the Sun event at IDWeek 2020.
Medscape Infectious Diseases, November 16, 2020
'Warning Lights' Ahead: Insights From COVID Epidemiology What can we learn from COVID surveillance and epidemiology thus far for the months ahead? Dr Paul Auwaerter discusses presentations from Chasing the Sun at IDWeek 2020.
Medscape Infectious Diseases, October 29, 2020

No Results